Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Cancer 8, 741 (1 October 2008) | doi:10.1038/nrc2512
Epigenetics: Rewriting the ending
Abstract
Maintaining the length of telomeres is vital if rapidly dividing tumour cells are to attain immortality. Thus telomerase, which shows high levels of activity in 90% of tumours, is an important target for anticancer therapy.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
